Recon: FDA to replace some fired workers with contractors; Pfizer abandons development of GLP-1 weight-loss drug
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States